2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Nationwide Trends and Hospital Outcomes of Revascularization Studied in PAD Patients With End-Stage Renal Disease on Hemodialysis

October 19, 2017 -- A study that aimed to describe the temporal trends and outcomes of endovascular and surgical revascularization in a large, nationally representative sample…

INSIGHT Study Begins for Avinger's Pantheris Lumivascular Atherectomy System to Treat In-Stent Restenosis

October 19, 2017 -- Avinger, Inc. announced the initiation of the INSIGHT trial to evaluate the safety and effectiveness of the company's Pantheris Lumivascular atherectom…

Study Shows Black Patients Present With More Advanced Disease at Time of Initial Major Vascular Interventions

October 18, 2017 -- In Journal of Vascular Surgery (JVS), Peter A. Soden, MD, et al published findings online ahead of print from a study that aimed to evaluate differences in…

Data Published for Medtronic's In.Pact Admiral DCB in De Novo In-Stent Restenosis

October 18, 2017 -- Findings from the IN.PACT Global study's de novo in-stent restenosis (ISR) imaging cohort were published by Marianne Brodmann, MD, et al in Journal of …

Meta-Analysis Evaluates Outcomes of Arteriovenous Fistula for Hemodialysis

October 18, 2017 -- In European Journal of Vascular and Endovascular Surgery (EJVES), Lauren C. Bylsma, MPH, et al published findings from a systematic review and meta-analysi…

BD Acquisition of Bard Receives Conditional Clearance From European Commission

October 18, 2017 -- BD (Becton, Dickinson and Company) announced clearance by the European Commission to acquire CR Bard, contingent on BD divesting its soft tissue core needl…

Click here for more News coverage

Current Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Setting Standards. Exceeding Expectations.

Interventional Oncology Tools & Techniques

Current European Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Drug-Eluting Technologies

Choosing the Best Option Through Data-Informed Decision Making.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Johnson and Johnson $142.40  0.25%
Vascular Market Price  Change

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.